PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

Abstract Background Several lipid guidelines recommend that proprotein convertase subtilisin/kexin type 9 inhibitors should be considered for patients with atherosclerotic cardiovascular disease who are inadequately treated with maximally tolerated lipid-lowering treatment. Objectives The PEARL stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Klaus G. Parhofer (Author), Berndt von Stritzky (Author), Nicole Pietschmann (Author), Cornelia Dorn (Author), W. Dieter Paar (Author)
Format: Book
Published: Adis, Springer Healthcare, 2019-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available